INTRODUCTION: The gold standard in organ preservation is static cold storage (SCS) using University of Wisconsin solution (UW). Although it is well-known that there is a finite limit to SCS preservation, and that there is a correlation between the adenosine triphosphate (ATP) levels and organ function post-preservation, a quantitative relationship has not been established, which is important in understanding the fundamental limitations to preservation, minimizing cold ischemic injury, and hence maximizing use of the donor organ pool. AIM: This study determines the time limits of cellular viability and metabolic function during SCS, and characterizes the relationship between cellular viability and energetic state using clinically relevant techniques in organ preservation. METHODS: Rat livers were procured and stored using conventional storage in UW solution at 4 °C. Viability was assessed by determining the amount of viable hepatocytes and intracellular ATP content after 0, 24, 48, 72, and 120 hours of storage. RESULTS: Numbers of viable hepatocytes that were isolated from these livers decreased steadily during SCS. After 5 days, viable hepatocytes decreased from 25.95 × 10(6) to 0.87 × 10(6) cells/gram tissue. Intracellular ATP content decreased from 9.63 to 0.93 moles/g tissue. Statistical analysis of variance established a linear relation for both parameters as a function of time (P < .05). CONCLUSION: The linear correlation between hepatocyte viability, ATP content, and storage time suggests a shared physiological foundation. These findings confirm ATP as direct predictor for organ quality in the context of liver preservation, which will aid quantitative assessment of donor organs for various applications.
INTRODUCTION: The gold standard in organ preservation is static cold storage (SCS) using University of Wisconsin solution (UW). Although it is well-known that there is a finite limit to SCS preservation, and that there is a correlation between the adenosine triphosphate (ATP) levels and organ function post-preservation, a quantitative relationship has not been established, which is important in understanding the fundamental limitations to preservation, minimizing cold ischemic injury, and hence maximizing use of the donor organ pool. AIM: This study determines the time limits of cellular viability and metabolic function during SCS, and characterizes the relationship between cellular viability and energetic state using clinically relevant techniques in organ preservation. METHODS:Rat livers were procured and stored using conventional storage in UW solution at 4 °C. Viability was assessed by determining the amount of viable hepatocytes and intracellular ATP content after 0, 24, 48, 72, and 120 hours of storage. RESULTS: Numbers of viable hepatocytes that were isolated from these livers decreased steadily during SCS. After 5 days, viable hepatocytes decreased from 25.95 × 10(6) to 0.87 × 10(6) cells/gram tissue. Intracellular ATP content decreased from 9.63 to 0.93 moles/g tissue. Statistical analysis of variance established a linear relation for both parameters as a function of time (P < .05). CONCLUSION: The linear correlation between hepatocyte viability, ATP content, and storage time suggests a shared physiological foundation. These findings confirm ATP as direct predictor for organ quality in the context of liver preservation, which will aid quantitative assessment of donor organs for various applications.
Authors: Y W Cho; T Shah; E S Cho; M Stadtler; V Simmons; T Mone; R Mendez; I V Hutchinson; J Gill; S Bunnapradist Journal: Transplant Proc Date: 2008-05 Impact factor: 1.066
Authors: Gero Puhl; Peter Olschewski; Wenzel Schöning; Gerhard Hunold; Hans-Georg Liesaus; Robert Winkler; Ulf P Neumann; Thomas E O Schubert; Volker Schmitz; Peter Neuhaus Journal: Liver Transpl Date: 2006-12 Impact factor: 5.799
Authors: L Makowka; R D Gordon; S Todo; N Ohkohchi; J W Marsh; A G Tzakis; H Yokoi; J Ligush; C O Esquivel; M Satake Journal: Transplant Proc Date: 1987-02 Impact factor: 1.066
Authors: Peter Olschewski; Gerhard Hunold; Christian Eipel; Ulf Neumann; Wenzel Schöning; Volker Schmitz; Brigitte Vollmar; Peter Neuhaus; Gero Puhl Journal: Transpl Int Date: 2008-08-05 Impact factor: 3.782
Authors: Tom P Theruvath; Zhi Zhong; Peter Pediaditakis; Venkat K Ramshesh; Robert T Currin; Andrey Tikunov; Ekhson Holmuhamedov; John J Lemasters Journal: Hepatology Date: 2008-01 Impact factor: 17.425
Authors: B G Bruinsma; H Yeh; S Ozer; P N Martins; A Farmer; W Wu; N Saeidi; S Op den Dries; T A Berendsen; R N Smith; J F Markmann; R J Porte; M L Yarmush; K Uygun; M-L Izamis Journal: Am J Transplant Date: 2014-04-23 Impact factor: 8.086
Authors: Maria-Louisa Izamis; Candice Calhoun; Basak E Uygun; Maria Angela Guzzardi; Gavrielle Price; Martha Luitje; Nima Saeidi; Martin L Yarmush; Korkut Uygun Journal: Cell Med Date: 2013
Authors: Bote G Bruinsma; Tim A Berendsen; Maria-Louisa Izamis; Martin L Yarmush; Korkut Uygun Journal: Int J Artif Organs Date: 2013-10-02 Impact factor: 1.595
Authors: Nir I Nativ; Alvin I Chen; Gabriel Yarmush; Scot D Henry; Jay H Lefkowitch; Kenneth M Klein; Timothy J Maguire; Rene Schloss; James V Guarrera; Francois Berthiaume; Martin L Yarmush Journal: Liver Transpl Date: 2013-12-12 Impact factor: 5.799
Authors: Bote G Bruinsma; Tim A Berendsen; Maria-Louisa Izamis; Heidi Yeh; Martin L Yarmush; Korkut Uygun Journal: Nat Protoc Date: 2015-02-18 Impact factor: 13.491